Back to Search Start Over

Peripheral Delivery of Neural Precursor Cells Ameliorates Parkinson’s Disease-Associated Pathology

Authors :
George Edwards III
Nazaret Gamez
Enrique Armijo
Carlos Kramm
Rodrigo Morales
Kathleen Taylor-Presse
Paul E. Schulz
Claudio Soto
Ines Moreno-Gonzalez
Source :
Cells, Vol 8, Iss 11, p 1359 (2019)
Publication Year :
2019
Publisher :
MDPI AG, 2019.

Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by loss of motor control due to a wide loss of dopaminergic neurons along the nigro-striatal pathway. Some of the mechanisms that contribute to this cell death are inflammation, oxidative stress, and misfolded alpha-synuclein-induced toxicity. Current treatments are effective at managing the early motor symptoms of the disease, but they become ineffective over time and lead to adverse effects. Previous research using intracerebral stem cell therapy for treatment of PD has provided promising results; however, this method is very invasive and is often associated with unacceptable side effects. In this study, we used an MPTP-injected mouse model of PD and intravenously administered neural precursors (NPs) obtained from mouse embryonic and mesenchymal stem cells. Clinical signs and neuropathology were assessed. Female mice treated with NPs had improved motor function and reduction in the neuroinflammatory response. In terms of safety, there were no tumorigenic formations or any detectable adverse effect after treatment. Our results suggest that peripheral administration of stem cell-derived NPs may be a promising and safe therapy for the recovery of impaired motor function and amelioration of brain pathology in PD.

Details

Language :
English
ISSN :
20734409
Volume :
8
Issue :
11
Database :
Directory of Open Access Journals
Journal :
Cells
Publication Type :
Academic Journal
Accession number :
edsdoj.2655f383085f4ba88ce6e93c7f58aa3b
Document Type :
article
Full Text :
https://doi.org/10.3390/cells8111359